Anti-Human SDF-1α (CXCL12) 0 ComentariosSubmit a Review Detalles del Producto Nùmero de Catalogo 500-P87A Descripcion Source: Polyclonal Rabbit Preparation: Produced from sera of rabbits immunized with highly pure Recombinant Human SDF-1alpha (CXCL12). Anti-Human SDF-1alpha (CXCL12)-specific antibody was purified by affinity chromatography employing immobilized Human SDF-1alpha (CXCL12) matrix. Immunogen: E.coli derived Recombinant Human SDF-1α (CXCL12) (PeproTech catalog# 300-28A) Sandwich ELISA: To detect Human SDF-1α by sandwich ELISA (using 100 μl/well antibody solution) a concentration of 0.5 - 2.0 μg/ml of this antibody is required. This antigen affinity purified antibody, in conjunction with PeproTech’s Biotinylated Anti-Human SDF-1α (500-P87ABt) as a detection antibody, allows the detection of at least 0.2 - 0.4 ng/well of recombinant Human SDF-1α. Western Blot: To detect Human SDF-1α by Western Blot analysis this antibody can be used at a concentration of 0.1-0.2 µg/ml. When used in conjunction with compatible secondary reagents, the detection limit for recombinant Human SDF-1α is 1.5-3.0 ng/lane, under either reducing or non-reducing conditions. Note: Additional applications tested on a lot-to-lot basis. Please contact Technical Support for more information. crossreactivity: Human, Mouse, Rat References SDS Búsqueda del CoA Product Line Country Of Origin: USA Not for human use. Research Interest AIDS/HIV Chemotaxis Immune System Inflammation Neurobiology Stem Cells & Differentiation Wound Healing product.subtitle.recentcitations Primer autor Hinderer, S Titulo Surface functionalization of electrospun scaffolds using recombinant human decorin attracts circulating endothelial progenitor cells. Citar Scientific Reports; 8(1) pg110 PudMed id 29311692 Primer autor Rao, S Titulo CXCL12 mediates trophic interactions between endothelial and tumor cells in glioblastoma. Citar PLoS ONE; 7(3) pge33005 PudMed id 22427929 Primer autor Cruz-Orengo, L Titulo CXCR7 influences leukocyte entry into the CNS parenchyma by controlling abluminal CXCL12 abundance during autoimmunity. Citar The Journal of Experimental Medicine; 208(2) pg327-39 PudMed id 21300915